Patients experiencing undiagnosed ADHD are frequently misdiagnosed with depression and anxiety, leading to ineffective or harmful medication side effects and prolonged struggles with unaddressed core symptoms.
Patients experiencing undiagnosed ADHD are frequently misdiagnosed with depression and anxiety, leading to ineffective or harmful medication side effects and prolonged struggles with unaddressed core symptoms.
Was I (17F)misdiagnosed with depression when ADHD might explain more of what I’m experiencing?
Was I (17F)misdiagnosed with depression when ADHD might explain more of what I’m experiencing?
Anxiety and depression were symptoms of another issue. The anxiety meds and antidepressants were like trying to put a bandaid on a bullet hole.
commentI was originally told I had anxiety, then PMDD/depression. Wellbutrin was hellish for me too. All anxiety meds and antidepressants were hellish. I gave up on them and used other remedies. My daughter started talking about ADHD, actually AuDHD. The more we talked about it and looked into it, the more it just made sense. I took her in to our family doctor to ask for an assessment for her. And I decided to ask for one too. Best decision I ever made. Anxiety and depression were symptoms of another issue. The anxiety meds and antidepressants were like trying to put a bandaid on a bullet hole. I believe they are way too quickly prescribed in healthcare imo. But, as my family doctor said, "I'm a doctor, at the end of the day I treat symptoms."
Individuals struggling with focus and cognitive issues who have been mislabeled with mood disorders and want structured self-advocacy tools for clinical assessments.
Multiple recurring comments detailing severe negative side effects from antidepressants and shared frustration over initial misdiagnoses of ADHD as depression or anxiety.
Purpose-built to bridge the gap between self-research and clinical validation specifically for overlooked demographics like teen girls and adults misdiagnosed with anxiety.
A structured symptom-tracking and documentation platform that helps users analyze executive dysfunction patterns, differentiate ADHD from mood disorders, and generate clinical-ready screening reports for primary care providers.
Users spend months or years suffering through trial-and-error antidepressant treatments and wasted co-pays; a $19 structured report that accelerates accurate diagnosis provides immediate personal ROI.
“Turn scattered symptoms into a clinician-ready ADHD assessment report in 6 weeks.”
A structured symptom-tracking and documentation platform that helps users analyze executive dysfunction patterns, differentiate ADHD from mood disorders, and generate clinical-ready screening reports for primary care providers.
Community-led outreach in ADHD, neurodivergence, and mental health support subreddits (r/ADHD, r/AuDHDWomen) and support groups.
Providing symptom analysis tools can inadvertently cross into perceived medical diagnosis, creating regulatory and liability exposure.
Traditional primary care physicians may dismiss patient-generated assessment reports brought in from online platforms.
Because report generation is a one-time need prior to diagnosis, retention as a subscription product is inherently challenging.
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoThis opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 9/10 against 3 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
It sits at the intersection of "adhd", "consumer-app", "diagnostics", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. Opportunities in this category typically reward founders who can describe the pain in the user's own language — both because that's the basis of effective marketing, and because it's the strongest signal that the founder has done the upfront listening. The MonetScope pipeline surfaces this category alongside other other signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most other opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.
